Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

On Tuesday, the Labor Department reported that the Consumer Price Index for April rose by only 0.2 percent last month, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The firm's Genomics revenues increased 89 percent, while Data and Services revenues rose 43 percent year over year.

Tempus AI continued to see dramatic revenue and gross profit growth in the first quarter, with year-over-year revenue up 75.4 ...

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Tuesday reported a loss of $68 million in its first quarter. On a per-share basis, the Chicago-based company said it had a loss of 40 cents.

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

Alongside our long-standing obsession with artisanally crafted cuisine rests a similar fixation on elevated cocktails crafted ...

Pathos AI, a Chicago biotech led by executives of the healthcare AI group Tempus, is looking at a funding round of up to $400 ...

Sarah Longwell, Publisher for The Bulwark and Robert Armstrong, US Financial Commentator for The Financial Times join Nicolle Wallace on Deadline White House to discuss who appear to be bearing the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication ...

The new, proprietary target discovery platform integrates RWD, human biological modeling, and CRISPR screens to accelerate novel target identification CHICAGO, April 28, 2025--(BUSINESS WIRE)--Tempus ...